184 related articles for article (PubMed ID: 25270620)
21. A toxicogenomics approach for early assessment of potential non-genotoxic hepatocarcinogenicity of chemicals in rats.
Uehara T; Hirode M; Ono A; Kiyosawa N; Omura K; Shimizu T; Mizukawa Y; Miyagishima T; Nagao T; Urushidani T
Toxicology; 2008 Aug; 250(1):15-26. PubMed ID: 18619722
[TBL] [Abstract][Full Text] [Related]
22. Detection of genotoxic and non-genotoxic carcinogens in Xpc(-/-)p53(+/-) mice.
Melis JP; Speksnijder EN; Kuiper RV; Salvatori DC; Schaap MM; Maas S; Robinson J; Verhoef A; van Benthem J; Luijten M; van Steeg H
Toxicol Appl Pharmacol; 2013 Jan; 266(2):289-97. PubMed ID: 23153559
[TBL] [Abstract][Full Text] [Related]
23. Literature-based compound profiling: application to toxicogenomics.
Frijters R; Verhoeven S; Alkema W; van Schaik R; Polman J
Pharmacogenomics; 2007 Nov; 8(11):1521-34. PubMed ID: 18034617
[TBL] [Abstract][Full Text] [Related]
24. Mode of action-based risk assessment of genotoxic carcinogens.
Hartwig A; Arand M; Epe B; Guth S; Jahnke G; Lampen A; Martus HJ; Monien B; Rietjens IMCM; Schmitz-Spanke S; Schriever-Schwemmer G; Steinberg P; Eisenbrand G
Arch Toxicol; 2020 Jun; 94(6):1787-1877. PubMed ID: 32542409
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach.
Hernández LG; van Steeg H; Luijten M; van Benthem J
Mutat Res; 2009; 682(2-3):94-109. PubMed ID: 19631282
[TBL] [Abstract][Full Text] [Related]
26. Gene expression and cytosine DNA methylation alterations in induced pluripotent stem-cell-derived human hepatocytes treated with low doses of chemical carcinogens.
Tryndyak V; Borowa-Mazgaj B; Beland FA; Pogribny IP
Arch Toxicol; 2019 Nov; 93(11):3335-3344. PubMed ID: 31555880
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the expression profiles induced by genotoxic and nongenotoxic carcinogens in rat liver.
Ellinger-Ziegelbauer H; Stuart B; Wahle B; Bomann W; Ahr HJ
Mutat Res; 2005 Aug; 575(1-2):61-84. PubMed ID: 15890375
[TBL] [Abstract][Full Text] [Related]
28. Assessing compound carcinogenicity in vitro using connectivity mapping.
Caiment F; Tsamou M; Jennen D; Kleinjans J
Carcinogenesis; 2014 Jan; 35(1):201-7. PubMed ID: 23940306
[TBL] [Abstract][Full Text] [Related]
29. Cross-platform toxicogenomics for the prediction of non-genotoxic hepatocarcinogenesis in rat.
Römer M; Eichner J; Metzger U; Templin MF; Plummer S; Ellinger-Ziegelbauer H; Zell A
PLoS One; 2014; 9(5):e97640. PubMed ID: 24830643
[TBL] [Abstract][Full Text] [Related]
30. Gene ontology mapping as an unbiased method for identifying molecular pathways and processes affected by toxicant exposure: application to acute effects caused by the rodent non-genotoxic carcinogen diethylhexylphthalate.
Currie RA; Bombail V; Oliver JD; Moore DJ; Lim FL; Gwilliam V; Kimber I; Chipman K; Moggs JG; Orphanides G
Toxicol Sci; 2005 Aug; 86(2):453-69. PubMed ID: 15901911
[TBL] [Abstract][Full Text] [Related]
31. Benzo[a]pyrene-induced transcriptomic responses in primary hepatocytes and in vivo liver: toxicokinetics is essential for in vivo-in vitro comparisons.
van Kesteren PC; Zwart PE; Schaap MM; Pronk TE; van Herwijnen MH; Kleinjans JC; Bokkers BG; Godschalk RW; Zeilmaker MJ; van Steeg H; Luijten M
Arch Toxicol; 2013 Mar; 87(3):505-15. PubMed ID: 23052197
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of 12 mouse marker genes in rat toxicogenomics public data, Open TG-GATEs: Discrimination of genotoxic from non-genotoxic hepatocarcinogens.
Furihata C; Suzuki T
Mutat Res Genet Toxicol Environ Mutagen; 2019 Feb; 838():9-15. PubMed ID: 30678831
[TBL] [Abstract][Full Text] [Related]
33. Identification of potential biomarkers of genotoxicity and carcinogenicity in L5178Y mouse lymphoma cells by cDNA microarray analysis.
Kim JY; Kwon J; Kim JE; Koh WS; Chung MK; Yoon S; Song CW; Lee M
Environ Mol Mutagen; 2005; 45(1):80-9. PubMed ID: 15612046
[TBL] [Abstract][Full Text] [Related]
34. Characterisation of cisplatin-induced transcriptomics responses in primary mouse hepatocytes, HepG2 cells and mouse embryonic stem cells shows conservation of regulating transcription factor networks.
Rieswijk L; Lizarraga D; Brauers KJ; Kleinjans JC; van Delft JH
Mutagenesis; 2014 Jan; 29(1):17-26. PubMed ID: 24280081
[TBL] [Abstract][Full Text] [Related]
35. Baseline and genotoxic compound induced gene expression profiles in HepG2 and HepaRG compared to primary human hepatocytes.
Jetten MJ; Kleinjans JC; Claessen SM; Chesné C; van Delft JH
Toxicol In Vitro; 2013 Oct; 27(7):2031-40. PubMed ID: 23911569
[TBL] [Abstract][Full Text] [Related]
36. Application of toxicogenomics to genetic toxicology risk assessment.
Thybaud V; Le Fevre AC; Boitier E
Environ Mol Mutagen; 2007 Jun; 48(5):369-79. PubMed ID: 17567850
[TBL] [Abstract][Full Text] [Related]
37. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
[TBL] [Abstract][Full Text] [Related]
38. Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity.
Yildirimman R; Brolén G; Vilardell M; Eriksson G; Synnergren J; Gmuender H; Kamburov A; Ingelman-Sundberg M; Castell J; Lahoz A; Kleinjans J; van Delft J; Björquist P; Herwig R
Toxicol Sci; 2011 Dec; 124(2):278-90. PubMed ID: 21873647
[TBL] [Abstract][Full Text] [Related]
39. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
Waters MD; Jackson M; Lea I
Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
[TBL] [Abstract][Full Text] [Related]
40. Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification.
Jennen DG; Magkoufopoulou C; Ketelslegers HB; van Herwijnen MH; Kleinjans JC; van Delft JH
Toxicol Sci; 2010 May; 115(1):66-79. PubMed ID: 20106945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
